Mayo Clinic Talks

Ana I. Casanegra, M.D., M.S., a vascular medicine specialist from the Mayo Clinic, dives into the world of venous thrombosis. She discusses the historical understanding of the condition and its serious complications, particularly pulmonary embolism. Key topics include risk factors like age and lifestyle, symptoms to watch for, and essential diagnostic tools. Dr. Casanegra also explores treatment options, including anticoagulants, while emphasizing the importance of personalized patient care and adherence to treatment strategies.

Hosts: Chatura Alur, M.D., M.P.H. | Meghan G. Theofiles, M.D.  Guest: Julie A. Lamppa, APRN, CNM  Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”.  Today, we’re back with Julie A. Lamppa, APRN, CNM, director of our midwifery services at Mayo Clinic Rochester and director of the Early Pregnancy Care Clinic at Mayo Clinic in Rochester. For this episode, we will be continuing our conversation about first trimester bleeding but going more towards how it relates to pregnancy loss.  To learn more about this series, click here  Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Hosts: Chatura Alur, M.D., M.P.H. | Meghan G. Theofiles, M.D.  Guest: Julie A. Lamppa, APRN, CNM  Welcome to our OB/GYN mini-series! “Help me OB/GYN! You’re my only hope”.  This podcast edition is specifically designed for the non-OB/GYN frontline provider.   Today, we’re going to be addressing first trimester bleeding and we are joined by our content expert, Julie A. Lamppa, APRN, CNM. She is the director of our midwifery services at Mayo Clinic Rochester and the director of the Early Pregnancy Care Clinic at Mayo Clinic in Rochester.  To learn more about this series, click here  Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Craig N. Sawchuk, Ph.D., L.P. It’s estimated that 1 in 40 adults have obsessive compulsive disorder. Obsessions are repetitive, unwanted thoughts that are very difficult to control. They commonly cause distress and anxiety and are often focused on a specific theme such as germs and contamination. Compulsions are repetitive behaviors or thoughts that help make the obsessive thoughts go away. They can be very time consuming and prevent the individual from participating in activities the person values. Treatment is available for patients with OCD, and most can be helped. We’ll discuss OCD with our guest, Craig N. Sawchuk, Ph.D., L.P., a psychologist at the Mayo Clinic and find out how patients with OCD present, common obsessions they experience and how OCD can be managed. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Denise M. Dupras, M.D., Ph.D. Guest: Isa J. Houwink, M.D., Ph.D. Pharmacogenomics (PGx) is transforming everyday primary care practice. By using patients’ genetic profiles, providers are guiding more precise, personalized treatments. In this episode of Genes & Your Health podcast, primary care physicians Dr. Denise Dupra and Dr. Isa J. Houwink discuss their practical applications and integration of PGx. The tips, tools and case studies shared, including how to optimize medication outcomes, reduce adverse drug reactions and deliver better patient care, is beneficial for all primary care providers. Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Denise M. Dupras, M.D., Ph.D. Guest: Margot A. Cousin, Ph.D. This episode of Genes & Your Health provides a comprehensive look at how ASO (Antisense Oligonucleotide) therapy is paving the way for personalized medicine and offering new hope for patients with previously untreatable conditions. Margot A. Cousin, Ph.D., an Assistant Professor of Medical Genetics in the Department of Molecular Medicine and Director of the N-or-1 Therapeutics Program in the Center for Individualized Medicine, walks us through an overview of what antisense oligonucleotides are and how they work.  We then discuss clinical applications, success stories, and potential new applications to transform treatment approaches.  Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Mark A. Frye, M.D. We have a variety of antidepressant medications available to us including SSRI’s, SNRI’s and others, and for the most part they’re very well tolerated by our patients. They are much better tolerated compared to some of our older options such as the tricyclic antidepressants and MAO inhibitors. These older products often produced cardiovascular and anticholinergic adverse effects, not commonly seen with our newer medications.  However, our newer antidepressants do have a relatively common adverse effect. They tend to produce weight changes, usually a weight increase. Which antidepressants tend to produce the most weight gain? How much weight does the typical patient gain from these medications? Is the weight gained typically maintained or lost when the medication is stopped? In this podcast, I’ll be discussing these questions and more with Mark A. Frye, M.D., a psychiatrist at the Mayo Clinic. To learn more about this topic: https://pubmed.ncbi.nlm.nih.gov/38950403/ Join us at the Swissotel in Chicago for two days of learning, networking, and advancing patient care. Seats are limited, so visit our website to register now! National Network of Depression Centers Best Practices for Mood Disorders in Collaboration with Mayo Clinic 2024 | Mayo Clinic School of Continuous Professional Development | CME Course Conference Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Host: Denise M. Dupras, M.D., Ph.D.  Guest: Marina Walther-Antonio, Ph.D. Can microbe populations affect women’s health in areas like ovarian cancer or predicting pre-term delivery? Tune into this episode of Genes & Your Health with Marina Walther-Antonio, Ph.D., a microbiome researcher within Mayo Clinic's Center for Individualized Medicine, to learn what recent research studies suggest about the interaction of the microbiome, the environment, and the genome.  Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Kristina M. Thurber, Pharm D., R.PH., specializes in obesity pharmacotherapy management at Mayo Clinic. In this discussion, she highlights the alarming obesity epidemic in the U.S. and the role of GLP-1 agonists in weight loss and diabetes management. Kristina explains how these medications work, their potential impact on weight loss expectations, and economic challenges facing patients. She also advocates for a holistic approach to obesity management, combining medication with lifestyle changes and emphasizes the importance of communication in patient care.

Host: Denise M. Dupras, M.D., Ph.D.  Guest: Jessica Kelly, JD Join our expert hosts as they delve into the intersection of genetic science and the legal landscape in this episode of Genes & Your Health.  Jessica Kelly, J.D., and Denise M. Dupras, M.D., Ph.D., discuss the latest advancements in genetic research, personalized medicine, and how these innovations are shaping the future of healthcare. They also explore the legal implications, from privacy concerns and ethical considerations to the policies governing genetic data usage and patient rights.  Whether you're a healthcare professional, a legal expert, or simply curious about the future of genetics, this episode offers valuable insights and thought-provoking discussions. Tune in to stay informed about the cutting-edge developments at the nexus of genetics and the law.  Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.